|
Behavioral Insomnia Therapy for Fibromyalgia Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for qualified medical advice, visits or professional assistance by using a real mD. We are not docs. Always confer with your physician about Behavioral Insomnia Therapy for Fibromyalgia conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Behavioral Insomnia Therapy for Fibromyalgia Clinical research trials and Behavioral Insomnia Therapy for Fibromyalgia health trials occur in many of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectivity of new does drugs. The intent of the studies / undertakings is to resolve particular human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to detect remedies for all sorts of conditions, including Behavioral Insomnia Therapy for Fibromyalgia. Behavioral Insomnia Therapy for Fibromyalgia Clinical Trials and other clinical trials permit volunteers to obtain healthcare treatment alternatives before they are available to the masses. Most times the participants undergo professional assistance for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Behavioral Insomnia Therapy for Fibromyalgia clinical trial. Test subjects typically receive the most expert healthcare available for their Behavioral Insomnia Therapy for Fibromyalgia condition. Dangers are a reality, however, and may include more or frequent mD visits, healthcare dangers (perhaps life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "B" Clinical Trials Conditions > Behavioral Insomnia Therapy for Fibromyalgia  Behavioral Insomnia Therapy for Fibromyalgia
Behavioral Insomnia Therapy for Fibromyalgia
For Condition: Fibromyalgia,Insomnia
Status: No longer recruiting
Sponsor(s): National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) ,
Synopsis: This study tests the effectiveness of a nondrug treatment for the insomnia that often occurs in people with fibromyalgia. The treatment is a type of psychotherapy called cognitive-behavioral therapy. Cognitive-behavioral therapy combines cognitive therapy, which can modify or eliminate thought patterns contributing to the person's symptoms, and behavioral therapy, which aims to help the person change his or her behavior.
Details: Fibromyalgia (FM) is a prevalent and debilitating condition that contributes to impaired occupational and social functioning and increased disability among affected individuals. The vast majority of people with FM experience persistent sleep disturbances (e.g., onset difficulty, repeated or extended awakenings, nonrestorative sleep) that worsen other FM-related symptoms (e.g., chronic pain, fatigue) and sustain their general dysfunction. Pharmacologic treatments (e.g., antidepressants, hypnotics) may reduce symptoms for some people with FM, but many FM patients display little enduring improvement in their sleep and other FM-related symptoms in response to such agents. Our clinical observations and initial pilot work suggest that factors common among other insomnia subtypes such as conditioned bedtime arousal, erratic sleep/wake scheduling, and spending too much time in bed likely perpetuate the sleep problems of these medication-refractory FM patients. Over the past decade, we have developed, refined, and repeatedly tested a cognitive-behavioral therapy (CBT) that has proven effective for reducing sleep disturbances perpetuated by such underlying cognitive/behavioral mechanisms. The major objectives of this project are to conduct a prospective randomized clinical trial to confirm these preliminary findings and to determine the efficacy of CBT insomnia treatment for interrupting the disturbed nocturnal sleep and daytime pain, fatigue, and distress symptom complex that defines FM. One arm of this study's three-by-four factorial design will compare CBT with both a contact control treatment and standard care. The other arm in the design is a repeated-measures factor consisting of four time points (i.e., baseline, mid-treatment, post-treatment, and 6-month follow-up periods) at which we will assess outcome. We will assess participants at all four time points with objective (wrist actigraphy) and subjective (sleep logs, Insomnia Symptom Questionnaire) measures of sleep improvements, measures of subjective pain, and questionnaires that assess mood (State-Trait Anxiety and Beck Depression Scales) and general quality of life (SF-36). We will conduct multivariate statistical analyses and tests of clinical significance with these various measures. We will also conduct exploratory analyses to determine if polysomnographically-derived sleep measures obtained prior to treatment correlate with initial levels of pain and distress or eventual treatment outcome. Results should provide information about the usefulness of CBT for treating FM-related sleep difficulties. Results should also improve understanding of the FM syndrome in general and provide new information about the potential role of behavioral therapy in the overall management of this disorder. Individuals interested in participating in this study should live within reasonable commuting distance from the Duke University Medical Center (Durham, NC), because this research requires multiple outpatient visits for screening and treatment.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study
Minimum Age/Maximum Age: 21 Years/65 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Insomnia for more than 1 month - Fibromyalgia diagnosis - Participants must live within easy commuting distance of Duke Medical Center, Durham, North Carolina Exclusion Criteria: - Terminal illness - Major psychiatric disorder - Substance abuse - Dependence on hypnotic drugs - Other sleep disorders (sleep apnea, restless legs, etc.) - Other sleep-disturbing medical disorders (painful arthritis, thyroid condition, etc.)
Total Enrollment: 60
Location and Contact Information:
Overall Study Official:
JackEdinger, Principal Investigator, VA Medical Center-Durham
Duke University Medical Center
Durham, North Carolina, 27710
United States
Additional Information:
Study ID Numbers: NIAMS-039; R21 AR46094
Study Start Date: July 1999
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000397
Other Insomnia Studies:
1. Behavioral Insomnia Therapy for Fibromyalgia
2. Yoga as a Treatment for Insomnia
3. Valerian to Improve Sleep in Patients with Parkinson's Disease
Related Studies:
Other Insomnia Clinical Trials
Other North Carolina Clinical Trials
Other Durham Clinical Trials
Behavioral Insomnia Therapy for Fibromyalgia
|
|
|
|
|
|
|
|
